BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:8b60fdba408bbdda5f68e701af9b4029
DTSTAMP:20260604T041921Z
DTSTART:20241113T150000
DTEND:20241113T163000
SUMMARY:WHO Global Priority Endemic Pathogens for Vaccine Research and Development (R&D)
DESCRIPTION:We are pleased to invite you to a webinar, in collaboration with TechNet, which will focus on: \nWHO Global Priority Endemic Pathogens for Vaccine Research and Development (R&D)\nWebinar details:\n\nDate: 13th November 2024\nTime: 15:00 hrs Geneva time\nDuration: 1.5 hours\nLink to register: http://tiny.cc/z0trzz\nFrench translation will be available\n\nWhy attend?\nWe are excited to invite you to join our upcoming webinar, where we will present and discuss the important work conducted by WHO on the prioritization of endemic pathogens for vaccine research and development (R&D). This initiative is part of the Immunization Agenda 2030 (IA2030), aimed at identifying the most critical pathogens for vaccine R&D based on regional and global public health needs. Don't miss this opportunity to explore how these findings can shape the future of vaccine development and enhance global health strategies.\nWhat will you learn?\n\nHow WHO systematically identified global priority endemic pathogens for vaccine R&D.\nThe role of multi-criteria decision analysis (MCDA) in setting vaccine R&D priorities.\nKey pathogens prioritized globally and across regions for new vaccine development.\nThe significance of aligning R&D priorities with regional public health needs.\n
X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\nWe are pleased to invite you to a webinar, in collaboration with TechNet, which will focus on:
WHO Global Priority Endemic Pathogens for Vaccine Research and Development (R&D)
Webinar details:
- Date: 13th November 2024
- Time: 15:00 hrs Geneva time
- Duration: 1.5 hours
- Link to register: http://tiny.cc/z0trzz
- French translation will be available
Why attend?
We are excited to invite you to join our upcoming webinar, where we will present and discuss the important work conducted by WHO on the prioritization of endemic pathogens for vaccine research and development (R&D). This initiative is part of the Immunization Agenda 2030 (IA2030), aimed at identifying the most critical pathogens for vaccine R&D based on regional and global public health needs. Don't miss this opportunity to explore how these findings can shape the future of vaccine development and enhance global health strategies.
What will you learn?
- How WHO systematically identified global priority endemic pathogens for vaccine R&D.
- The role of multi-criteria decision analysis (MCDA) in setting vaccine R&D priorities.
- Key pathogens prioritized globally and across regions for new vaccine development.
- The significance of aligning R&D priorities with regional public health needs.
\n\n\n
LOCATION:
END:VEVENT
END:VCALENDAR